Torino C et al. |
Vitamin D and methylarginines in chronic kidney disease (CKD). |
2017 |
PLoS ONE |
pmid:28976989
|
Chung S et al. |
Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin. |
2017 |
PLoS ONE |
pmid:28753620
|
Xun J et al. |
JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity. |
2017 |
Oncotarget |
pmid:28423536
|
Poveda J et al. |
MXRA5 is a TGF-β1-regulated human protein with anti-inflammatory and anti-fibrotic properties. |
2017 |
J. Cell. Mol. Med. |
pmid:27599751
|
Zheng JQ et al. |
Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients. |
2016 |
Nutrients |
pmid:27827962
|
Manjarres L et al. |
Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital. |
2016 |
BMC Health Serv Res |
pmid:27566059
|
Nieuwland AJ et al. |
Activation of the vitamin D receptor selectively interferes with calcineurin-mediated inflammation: a clinical evaluation in the abdominal aortic aneurysm. |
2016 |
Lab. Invest. |
pmid:27239732
|
El-Shemi AG et al. |
Paricalcitol Enhances the Chemopreventive Efficacy of 5-Fluorouracil on an Intermediate-Term Model of Azoxymethane-Induced Colorectal Tumors in Rats. |
2016 |
Cancer Prev Res (Phila) |
pmid:27020656
|
Lee AS et al. |
Paricalcitol attenuates lipopolysaccharide-induced myocardial inflammation by regulating the NF-κB signaling pathway. |
2016 |
Int. J. Mol. Med. |
pmid:26954764
|
Egido J et al. |
The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism. |
2016 |
Nefrologia |
pmid:26705959
|
Martinez-Moreno JM et al. |
Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells. |
2016 |
FASEB J. |
pmid:26700731
|
Riera M et al. |
Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria. |
2016 |
Am. J. Physiol. Renal Physiol. |
pmid:26697977
|
Becs G et al. |
Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells. |
2016 |
J. Cell. Mol. Med. |
pmid:26499096
|
Borrego Utiel FJ et al. |
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism. |
2015 |
Nefrologia |
pmid:26306956
|
Dauletbaev N et al. |
Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1. |
2015 |
Br. J. Pharmacol. |
pmid:26178144
|
Zerr P et al. |
Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. |
2015 |
Ann. Rheum. Dis. |
pmid:24448349
|
Brakta S et al. |
Role of vitamin D in uterine fibroid biology. |
2015 |
Fertil. Steril. |
pmid:26079694
|
Morgado-Pascual JL et al. |
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells. |
2015 |
Biomed Res Int |
pmid:26064952
|
Dáňová K et al. |
NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment. |
2015 |
Oncotarget |
pmid:26053099
|
Stavenuiter AW et al. |
A novel rat model of vitamin D deficiency: safe and rapid induction of vitamin D and calcitriol deficiency without hyperparathyroidism. |
2015 |
Biomed Res Int |
pmid:25815325
|